The effects of elexafactor/tezafactor/ivacaftor beyond the epithelium: spurring macrophages to fight infections
- PMID: 37003613
- DOI: 10.1183/13993003.00216-2023
The effects of elexafactor/tezafactor/ivacaftor beyond the epithelium: spurring macrophages to fight infections
Conflict of interest statement
Conflict of interest: The author declares no competing interests.
Comment on
-
Cystic fibrosis macrophage function and clinical outcomes after elexacaftor/tezacaftor/ivacaftor.Eur Respir J. 2023 Apr 1;61(4):2102861. doi: 10.1183/13993003.02861-2021. Print 2023 Apr. Eur Respir J. 2023. PMID: 36265882 Free PMC article.
-
Elexacaftor/tezacaftor/ivacaftor corrects monocyte microbicidal deficiency in cystic fibrosis.Eur Respir J. 2023 Apr 1;61(4):2200725. doi: 10.1183/13993003.00725-2022. Print 2023 Apr. Eur Respir J. 2023. PMID: 36455959 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical